Skip to main content
. 2018 Mar 30;14(2):225–233. doi: 10.3988/jcn.2018.14.2.225

Table 2. Primary and secondary outcomes measures assessed at T0, T1, and T2.

T0 T1 T2 p p Change ES
Pre-training Post-8 sessions Post-16 sessions T0 vs. T1 T1 vs. T2 T0 vs. T2 T0-T1 T1-T2 T0-T2 Post-16 sessions
Primary outcomes
 UPDRS III (off) 23.38±7.97 18.85±6.91 15.92±6.06 0.000 0.011 0.007 0.001 −4.54±5.21 −2.92±3.07 −7.46±4.45 −1.66
  Tremor subscores 0.85±1.07 0.77±1.36 0.77±1.09 0.939 0.705 1.00 0.564 −0.08±0.76 0.00±0.58 −0.08±0.49 −0.16
  Rigidity subscores 4.69±2.93 4.77±2.74 4.38±2.81 0.303 0.558 0.248 0.304 0.08±3.52 −0.38±1.12 −0.31±3.33 −0.09
  Akinesia subscores 9.54±3.76 6.54±2.85 5.54±2.33 0.001 0.009 0.041 0.003 −3.00±3.32 −1.00±1.53 −4.00±2.71 −1.48
  PIGD subscores 1.69±0.85 1.23±0.83 0.85±0.69 0.003 0.058 0.096 0.005 −0.46±0.78 −0.38±0.77 −0.85±0.69 −1.23
 UPDRS III (on) 15.46±5.56 14.00±6.65 11.38±5.68 0.009 0.254 0.037 0.004 −1.46±3.97 −2.62±4.01 −4.08±3.55 −1.15
  Tremor subscores 0.31±0.63 0.62±1.19 0.31±0.75 0.779 0.414 0.414 1.000 0.31±1.18 −0.31±1.18 0.00±0.41 0.00
  Rigidity subscores 3.77±2.62 3.31±2.02 2.54±2.5 0.145 0.337 0.151 0.106 −0.46±1.61 −0.77±1.79 −1.23±2.52 −0.49
  Akinesia subscores 5.92±2.69 5.15±2.88 4.46±2.22 0.033 0.280 0.102 0.005 −0.77±2.20 −0.69±1.60 −1.46±1.20 −1.22
  PIGD subscores 1.38±1.12 0.92±0.86 0.62±0.77 0.012 0.058 0.157 0.015 −0.46±0.78 −0.31±0.75 −0.77±0.83 −0.93
 TUG (on) 7.36±1.19 7.18±1.38 6.86±0.89 0.006 0.422 0.133 0.003 −0.18±0.70 −0.32±0.79 −0.50±0.57 −0.88
Secondary outcomes
 MoCA 27.62±1.61 - 29.23±0.83 - - - 0.004S - - 1.62±1.45 1.12
 mHYS (off) 1.96±0.48 - 1.62±0.62 - - - 0.014S - - −0.35±0.38 −0.92
 mHYS (on) 1.81±0.66 - 1.46±0.63 - - - 0.024S - - −0.35±0.43 −0.81
 UPDRS I (on) 1.92±1.04 - 1.38±0.65 - - - 0.100S - - −0.54±1.13 −0.48
 UPDRS II (on) 7.38±3.10 - 5.69±3.09 - - - 0.056S - - −1.69±2.78 −0.61
 UPDRS IV (on) 0.00±0.00 - 0.00±0.00 - - - 1.000S - - 0.00±0.00 -
 Total UPDRS (on) 24.77±7.78 - 18.46±7.92 - - - 0.005S - - −6.31±5.17 −1.22
 FES 31.15±12.21 - 29.15±10.86 - - - 0.824S - - −2.00±10.46 −0.19
 NFOGQ Non-freezer Non-freezer Non-freezer - - - - - - - -
 SE-ADL (%) 91.54±3.76 - 91.54±3.76 1.000S - - 0.00±4.08 -
 PDQ-39 23.15±15.76 - 18.62±11.84 - - - 0.421S - - −4.54±14.27 −0.32
 PGI-C (%)
  Very much improved - 1, 7.69 1, 7.69 - - - - - - - -
  Much improved - 4, 30.77 5, 38.46 - - - - - - - -
  Minimally improved - 7, 53.85 6, 46.15 - - - - - - - -
  No change - 1, 7.69 1, 7.69 - - - - - - - -

Change in negative value indicates improvement: mHYS, UPDRS, TUG, PDQ-39, FES.

Mean±SD, p: Friedman test, α=0.05; p′: Wilcoxon signed rank test, α=0.017; S: Wilcoxon signed rank test, α=0.05; ES (Chohn's d)=mean of change/SD; 0.2 small effect; 0.5 medium effect; 0.8 large effect; T0: Pre-training; T1: Post 8-session training, T2: Post 16-session training; Tremor subscores: item 20 (tremor at rest); Rigidity subscores: item 22 (rigidity); Akinesia subscores; items 23–26 (finger taps, hand movements, rapid alternating movements of the hands, and leg agility); PIGD subscores; items 29–30 (gait, postural stability).

ES: effect size, FES: Falls Efficacy Scale, mHYS: Modified Hoehn and Yahr, MoCA: Montreal Cognitive Assessment, NFOGQ: New Freezing of Gait Questionnaire, PDQ-39: 39-item Parkinson's Disease Questionnaire, PGI-C: Patient Global Impression of Change, SD-ADL: Schwab and England Activities of Daily Living, TUG: Timed Up and Go, UPDRS: Unified Parkinson's Disease Rating Scale.